Truist Securities Maintains Hold on Doximity, Raises Price Target to $29-Report released on 8th February 2024
Company Profile
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.